omeprazole
NDC 30142-992, omeprazole, tablet, delayed release, from THE KROGER COMPANY.
- Product NDC
- 30142-992
- Status
- Listed
- Labeler
- THE KROGER COMPANY
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA207891
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/30142-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 30142-992-14 | 30142099214 | 14 TABLET, DELAYED RELEASE in 1 BOTTLE (30142-992-14) |
| 30142-992-28 | 30142099228 | 2 TABLET, DELAYED RELEASE in 1 CARTON (30142-992-28) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 30142-992 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/30142-992 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 30142-992. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.